-
1
-
-
0037099683
-
Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results
-
Rodel C., Grabenbauer G.G., Kuhn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20 (2002) 3061-3071
-
(2002)
J Clin Oncol
, vol.20
, pp. 3061-3071
-
-
Rodel, C.1
Grabenbauer, G.G.2
Kuhn, R.3
-
2
-
-
0031985484
-
Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer
-
Sauer R., Birkenhake S., Kuhn R., et al. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 40 (1998) 121-127
-
(1998)
Int J Radiat Oncol Biol Phys
, vol.40
, pp. 121-127
-
-
Sauer, R.1
Birkenhake, S.2
Kuhn, R.3
-
3
-
-
0025912878
-
Dose fractionation and tumour repopulation in radiotherapy for bladder cancer
-
Maciejewski B., and Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol 21 (1991) 163-170
-
(1991)
Radiother Oncol
, vol.21
, pp. 163-170
-
-
Maciejewski, B.1
Majewski, S.2
-
5
-
-
0031785195
-
Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control
-
Moonen L., van der Voet H., de Nijs R., et al. Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control. Int J Radiat Oncol Biol Phys 42 (1998) 525-530
-
(1998)
Int J Radiat Oncol Biol Phys
, vol.42
, pp. 525-530
-
-
Moonen, L.1
van der Voet, H.2
de Nijs, R.3
-
6
-
-
18144406138
-
A randomised trial of accelerated radiotherapy for localised invasive bladder cancer
-
Horwich A., Dearnaley D., Huddart R., et al. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer. Radiother Oncol 75 (2005) 34-43
-
(2005)
Radiother Oncol
, vol.75
, pp. 34-43
-
-
Horwich, A.1
Dearnaley, D.2
Huddart, R.3
-
7
-
-
0030949541
-
Hypofractionated radiotherapy for invasive bladder cancer
-
Scholten A.N., Leer J.W., Collins C.D., et al. Hypofractionated radiotherapy for invasive bladder cancer. Radiother Oncol 43 (1997) 163-169
-
(1997)
Radiother Oncol
, vol.43
, pp. 163-169
-
-
Scholten, A.N.1
Leer, J.W.2
Collins, C.D.3
-
8
-
-
0032727504
-
Hypofractionated radiotherapy for patients with carcinoma of the bladder
-
Jose C.C., Price A., Norman A., et al. Hypofractionated radiotherapy for patients with carcinoma of the bladder. Clin Oncol 11 (1999) 330-333
-
(1999)
Clin Oncol
, vol.11
, pp. 330-333
-
-
Jose, C.C.1
Price, A.2
Norman, A.3
-
9
-
-
0033663646
-
The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response
-
Kaufman D.S., Winter K.A., Shipley W.U., et al. The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response. Oncologist 5 (2000) 471-476
-
(2000)
Oncologist
, vol.5
, pp. 471-476
-
-
Kaufman, D.S.1
Winter, K.A.2
Shipley, W.U.3
-
10
-
-
33644510453
-
Radical radiotherapy for invasive bladder cancer: what dose and fractionation schedule to choose?
-
Pos F.J., Hart G., Schneider C., et al. Radical radiotherapy for invasive bladder cancer: what dose and fractionation schedule to choose?. Int J Radiat Oncol Biol Phys 64 (2006) 1168-1173
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.64
, pp. 1168-1173
-
-
Pos, F.J.1
Hart, G.2
Schneider, C.3
-
11
-
-
6344226304
-
Conformal hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC) for high risk prostatic carcinoma: rationale, technique and early experience
-
Koukourakis M.I., Touloupidis S., Manavis J., et al. Conformal hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC) for high risk prostatic carcinoma: rationale, technique and early experience. Anticancer Res 24 (2004) 3239-3243
-
(2004)
Anticancer Res
, vol.24
, pp. 3239-3243
-
-
Koukourakis, M.I.1
Touloupidis, S.2
Manavis, J.3
-
12
-
-
0036137527
-
Tumor and Angiogenesis Research Group: Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients
-
Koukourakis M.I., Giatromanolaki A., Kouroussis C., et al. Tumor and Angiogenesis Research Group: Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients. Int J Radiat Oncol Biol Phys 52 (2002) 144-155
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.52
, pp. 144-155
-
-
Koukourakis, M.I.1
Giatromanolaki, A.2
Kouroussis, C.3
-
13
-
-
0030827548
-
The biodistribution and pharmacokinetics of stealth liposomes in patients with solid tumors
-
Stewart S., and Harrington K.J. The biodistribution and pharmacokinetics of stealth liposomes in patients with solid tumors. Oncology 11 suppl 11 (1997) 33-36
-
(1997)
Oncology
, vol.11
, Issue.SUPPL. 11
, pp. 33-36
-
-
Stewart, S.1
Harrington, K.J.2
-
14
-
-
0034065024
-
High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas-rationale for combination with radiotherapy
-
Koukourakis M.I., Koukouraki S., Giatromanolaki A., et al. High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas-rationale for combination with radiotherapy. Acta Oncol 39 (2000) 207-211
-
(2000)
Acta Oncol
, vol.39
, pp. 207-211
-
-
Koukourakis, M.I.1
Koukouraki, S.2
Giatromanolaki, A.3
-
15
-
-
0032700799
-
Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer
-
Koukourakis M.I., Koukouraki S., Giatromanolaki A., et al. Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer. J Clin Oncol 17 (1999) 3512-3521
-
(1999)
J Clin Oncol
, vol.17
, pp. 3512-3521
-
-
Koukourakis, M.I.1
Koukouraki, S.2
Giatromanolaki, A.3
-
16
-
-
0028708636
-
LQ-based model for biological radiotherapy planning
-
Koukourakis M.I., and Damilakis J. LQ-based model for biological radiotherapy planning. Med Dosim 19 (1994) 269-277
-
(1994)
Med Dosim
, vol.19
, pp. 269-277
-
-
Koukourakis, M.I.1
Damilakis, J.2
-
17
-
-
33745552177
-
Individualization of the subcutaneous amifostine dose during hypofractionated/accelerated radiotherapy
-
Koukourakis M.I., Abatzoglou I., Sivridis L., et al. Individualization of the subcutaneous amifostine dose during hypofractionated/accelerated radiotherapy. Anticancer Res 26 (2006) 2437-2443
-
(2006)
Anticancer Res
, vol.26
, pp. 2437-2443
-
-
Koukourakis, M.I.1
Abatzoglou, I.2
Sivridis, L.3
-
18
-
-
4444367495
-
Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP)
-
Boccia R., Anne P.R., Bourhis J., et al. Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP). Int J Radiat Oncol Biol Phys 60 (2004) 302-309
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.60
, pp. 302-309
-
-
Boccia, R.1
Anne, P.R.2
Bourhis, J.3
-
19
-
-
18544409287
-
Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
-
Fu K.K., Pajak T.F., Trotti A., et al. Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
-
(2000)
Int J Radiat Oncol Biol Phys
, vol.48
, pp. 7-16
-
-
Fu, K.K.1
Pajak, T.F.2
Trotti, A.3
-
20
-
-
0030737527
-
Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomized multicentre trial
-
CHART Steering Committee
-
Saunders M., Dische S., Barrett A., et al., CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomized multicentre trial. Lancet 350 (1997) 161-165
-
(1997)
Lancet
, vol.350
, pp. 161-165
-
-
Saunders, M.1
Dische, S.2
Barrett, A.3
-
21
-
-
0035924216
-
Invasive bladder carcinoma: a pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin
-
Zouhair A., Ozsahin M., Schneider D., et al. Invasive bladder carcinoma: a pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin. Int J Cancer 96 (2001) 350-355
-
(2001)
Int J Cancer
, vol.96
, pp. 350-355
-
-
Zouhair, A.1
Ozsahin, M.2
Schneider, D.3
-
22
-
-
0029851252
-
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation
-
National Cancer Institute of Canada Clinical Trials Group
-
Coppin C.M., Gospodarowicz M.K., James K., et al., National Cancer Institute of Canada Clinical Trials Group. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. J Clin Oncol 14 (1996) 2901-2907
-
(1996)
J Clin Oncol
, vol.14
, pp. 2901-2907
-
-
Coppin, C.M.1
Gospodarowicz, M.K.2
James, K.3
-
24
-
-
0034192172
-
A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of Medical Research Council Trial BA09
-
Duchesne G.M., Bolger J.J., Griffiths G.O., et al. A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of Medical Research Council Trial BA09. Int J Radiat Oncol Biol Phys 47 (2000) 379-388
-
(2000)
Int J Radiat Oncol Biol Phys
, vol.47
, pp. 379-388
-
-
Duchesne, G.M.1
Bolger, J.J.2
Griffiths, G.O.3
-
25
-
-
0030910421
-
Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly
-
McLaren D.B., Morrey D., and Mason M.D. Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly. Radiother Oncol 43 (1997) 171-174
-
(1997)
Radiother Oncol
, vol.43
, pp. 171-174
-
-
McLaren, D.B.1
Morrey, D.2
Mason, M.D.3
-
26
-
-
10044227869
-
Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy
-
Cowan R.A., McBain C.A., Ryder W.D., et al. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Int J Radiat Oncol Biol Phys 59 (2004) 197-207
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.59
, pp. 197-207
-
-
Cowan, R.A.1
McBain, C.A.2
Ryder, W.D.3
-
27
-
-
0037710386
-
Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial
-
Oncology Hellenic Group
-
Athanassiou H., Antonadou D., Coliarakis N., et al., Oncology Hellenic Group. Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial. Int J Radiat Oncol Biol Phys 56 (2003) 1154-1160
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.56
, pp. 1154-1160
-
-
Athanassiou, H.1
Antonadou, D.2
Coliarakis, N.3
-
28
-
-
23044501890
-
Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer
-
von der Maase H., Sengelov L., Roberts J.T., et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 23 (2005) 4602-4608
-
(2005)
J Clin Oncol
, vol.23
, pp. 4602-4608
-
-
von der Maase, H.1
Sengelov, L.2
Roberts, J.T.3
-
29
-
-
0035887279
-
Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC
-
Millikan R., Dinney C., Swanson D., et al. Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol 19 (2001) 4005-4013
-
(2001)
J Clin Oncol
, vol.19
, pp. 4005-4013
-
-
Millikan, R.1
Dinney, C.2
Swanson, D.3
-
30
-
-
0142089886
-
Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract
-
Winquist E., Ernst D.S., Jonker D., et al. Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract. Eur J Cancer 39 (2003) 1866-1871
-
(2003)
Eur J Cancer
, vol.39
, pp. 1866-1871
-
-
Winquist, E.1
Ernst, D.S.2
Jonker, D.3
|